Cite
MLA Citation
Andrew S. Brohl et al.. “A phase IB study of ipilimumab with peginterferon alfa-2b in patients with unresectable melanoma.” Journal for immunotherapy of cancer, vol. 4, no. 1, 2016, p. . http://access.bl.uk/ark:/81055/vdc_100144509749.0x000019